A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis

Starting soon · Phase 1 · Has a placebo group

Conditions studied: Ulcerative Colitis (UC)

In brief

A study to investigate the safety, tolerability, and pharmacokinetics (PK) of ONO-6414 orally in healthy adult participants and in patients with active ulcerative colitis (UC).

Key facts

Study ID
NCT07749768
Run by
Ono Pharmaceutical Co., Ltd.
People needed
90
Starts
2026-09-30
Expected to finish
2028-01-31
Last updated by the study team
2026-08-06

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.